SHINE
LIVE

Serial Number

50089624

Owner

Shine Technologies, LLC

Attorney

Tricia L. Schulz

Filing Date

Sep 3, 2026

Add to watchlist:

No watchlists yet
View on USPTO

SHINE Trademark

Serial Number: 50089624

SHINE is a trademark filed by Shine Technologies, LLC on September 3, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Shine Technologies, LLC

3400 Innovation Ct.
Janesville, WI 53546

Entity Type: 16

Trademark Details

Filing Date

September 3, 2026

Registration Date

Not Registered

Goods & Services

Distribution of energy; distribution and transmission of electricity

Medical and scientific research in the field of medical imaging and isotopes and radioisotopes for medical, therapeutic or diagnostic use; Development of isotopes and radioisotopes for medical, therapeutic or diagnostic use; research and development services in the fields of aerospace, energy systems, defense, transportation and nuclear technology; technical consulting, research, custom design and engineering services in the fields of aerospace, energy systems, defense, and nuclear technology; aerospace testing laboratory services; radiation effects testing services for scientific or medical research purposes; material testing services using neutrons; material and equipment testing services using fusion generated neutrons for scientific research purposes; laboratory research services for material and equipment testing using fusion generated neutrons; scientific research and development services in the fields of aerospace, energy systems, defense, transportation and nuclear technology; technology consulting, research, custom design and engineering services in the fields of aerospace, energy systems, defense, and nuclear technology; laboratory research services, namely, non-medical imaging services, non-medical neutron imaging services

Isotopes and radioisotopes for scientific or research use; Isotopes and radioisotopes for use in the manufacture of pharmaceutical preparations; Active chemical ingredients for use in the manufacture of pharmaceuticals, namely technetium-99m, lutetium-177, terbium-149, terbium-152, terbium-155, terbium-161, or actinium-225, for medical, therapeutic and diagnostic use

Isotopes and radioisotopes for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely non-carrier added lutetium-177; active pharmaceutical ingredients, namely, a radioisotope for the diagnosis and treatment of oncological diseases and disorders; active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases; parent radioisotopes for the preparation of active pharmaceutical ingredients, namely molybdenum-99; radio-isotope markers for therapeutic or diagnostic use; radioactive substances for use in nuclear medicine

Particle accelerator for medical purposes, namely, radiological treatment of tumors; neutron generators for medical purposes, radiological imaging and treatment of tumors; nuclear medicine diagnostic imaging apparatus; radioisotope therapy apparatus and instruments

Particle accelerators and parts and accessories therefor; neutron generators other than for medical purposes and parts and accessories therefor

Medical imaging services; Medical diagnostic neutron imaging services

Generation of neutrons for use in material and equipment testing; generation of neutrons using nuclear fusion for use in material and equipment testing; nuclear fuel recycling; transmutation of used nuclear fuel; processing of hazardous materials for decontamination; used nuclear fuel treatment and disposal; production and generation of energy utilizing nuclear energy systems

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 3, 2026 MAFR
NEW APPLICATION ENTERED
Sep 3, 2026 NWAP